Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents in combined treatment with cisplatin in ovarian cancer

Lookup NU author(s): Maryam Zanjirband Zanjirband, Professor Richard Edmondson, Emeritus Professor John LunecORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Publication metadata

Author(s): Zanjirband M, Edmondson RJ, Lunec J

Publication type: Article

Publication status: Published

Journal: Oncotarget

Year: 2016

Volume: 7

Issue: 26

Pages: 40115-40134

Online publication date: 20/05/2016

Acceptance date: 26/04/2016

Date deposited: 06/07/2016

ISSN (electronic): 1949-2553

Publisher: Impact Journals

URL: http://dx.doi.org/10.18632/oncotarget.9499

DOI: 10.18632/oncotarget.9499

PubMed id: 27223080


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Northern Cancer Care & Research Society
C0190R4011Newcastle University & Northern Institute for Cancer Research
C240/A1571Cancer Research UK
C27826/A11524Cancer Research UK

Share